Is there a role for vindesine in the treatment of non-small cell lung cancer?

[1]  U. Gatzemeier,et al.  A Randomized Trial with Mitomycin‐C/Ifosfamide Versus Mitomycin‐C/Vindesine Versus Cisplatin/Etoposide in Advanced Non‐Small-Cell Lung Cancer , 1991, American journal of clinical oncology.

[2]  M. Fukuoka,et al.  A randomized study of cisplatin versus cisplatin plus vindesine for non‐small cell lung carcinoma , 1991, Cancer.

[3]  K. Eguchi,et al.  A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer. , 1991, European journal of cancer.

[4]  J. von Pawel,et al.  Phase III trial with and without lonidamine in non-small cell lung cancer. , 1991, Seminars in oncology.

[5]  M. Fukuoka,et al.  A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Buzaid,et al.  Critical Analysis of Neoadjuvant Therapy for State Illa Non-Small Cell Lung Cancer , 1991 .

[7]  R. Arriagada,et al.  Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.

[8]  A. Piga,et al.  Chemotherapy or not in advanced non-small cell lung cancer? , 1990 .

[9]  C. Perez,et al.  Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. , 1990, Annals of internal medicine.

[10]  N. Thatcher,et al.  Preliminary experience with quality of life evaluation in patients with lung cancer. , 1990, Oncology.

[11]  L. Einhorn,et al.  Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Carles,et al.  A randomized study of two vindesine plus cisplatin‐containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non‐small cell lung cancer , 1990, Cancer.

[13]  J. Karstens,et al.  Initial tumor size and local control in stage III non-small cell lung cancer treated by radio-chemotherapy. , 1990, Onkologie.

[14]  CJ Williams,et al.  A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. , 1990, British Journal of Cancer.

[15]  H. Hansen,et al.  Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications. , 1989, British Journal of Cancer.

[16]  J. Hainsworth,et al.  Chemotherapy of Advanced Non‐Small‐Cell Lung Cancer: A Randomized Trial of Three cis‐Platin‐Based Chemotherapy Regimens , 1989, American journal of clinical oncology.

[17]  R. Weichselbaum,et al.  Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. , 1989, Chest.

[18]  S. Pyrhönen,et al.  A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer. , 1989, European journal of cancer & clinical oncology.

[19]  H. Warenius,et al.  Sequential combination chemotherapy and radiotherapy in locally advanced non-small cell carcinoma of the bronchus. , 1989, Respiratory medicine.

[20]  C. Williams,et al.  Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy. , 1988, Seminars in oncology.

[21]  M. Marangolo,et al.  Adjuvant chemotherapy of non-small cell lung cancer: a review. , 1988, Seminars in oncology.

[22]  P. van Houtte,et al.  Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study. , 1988, Antibiotics and chemotherapy.

[23]  Spain Rc.  Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress from the perspective of long-term follow-up. , 1988 .

[24]  J L Pater,et al.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Kris,et al.  The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0). , 1988, The Annals of thoracic surgery.

[26]  R. Figlin,et al.  Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index—cancer , 1988, Cancer.

[27]  W. Gregory,et al.  A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma. , 1987, European journal of cancer & clinical oncology.

[28]  C. Mountain,et al.  A new international staging system for lung cancer. , 1987, Chest.

[29]  H. Hansen,et al.  Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  R. Feld.  Quality of life in patients with non-small cell lung cancer treated with chemotherapy. , 1987, European journal of cancer & clinical oncology.

[31]  N. Aaronson,et al.  Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life. , 1986, European journal of cancer & clinical oncology.

[32]  A. Brandes,et al.  Cisplatin plus Vindesine versus Cisplatin plus VP16 versus Doxorubicin plus Cytoxan in Non-Small-Cell Carcinoma of the Lung. A Randomized Study , 1986, Tumori.

[33]  K. Eguchi,et al.  Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin. , 1986, Japanese journal of cancer research : Gann.

[34]  L. Einhorn,et al.  Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Gail,et al.  Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  D. Osoba,et al.  Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  K. Eguchi,et al.  Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer. , 1985, Cancer treatment reports.

[38]  K. Eguchi,et al.  Phase II study of vindesine in patients with non-small cell lung cancer. , 1985, Japanese journal of cancer research : Gann.

[39]  C. Mountain.  The biological operability of stage III non-small cell lung cancer. , 1985, The Annals of thoracic surgery.

[40]  R. Arriagada,et al.  Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung. , 1985, Cancer treatment reports.

[41]  S. Groshen,et al.  Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment. , 1985, Cancer treatment reports.

[42]  M. Valdivieso,et al.  Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  R. J. Cersosimo,et al.  A Prospective Randomized Trial of Combination Vindesine and Cisplatin Versus Single‐agent Vindesine in Advanced Non‐small Cell Lung Cancer , 1985, Pharmacotherapy.

[44]  J. Clavier,et al.  Surgery and chemotherapy. A new method of treatment for squamous cell bronchial carcinoma. , 1984, The Journal of thoracic and cardiovascular surgery.

[45]  I. Tannock,et al.  Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  R. Stevenson,et al.  Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. , 1984, European journal of cancer & clinical oncology.

[47]  Clark Gm,et al.  Phase II trial of vindesine in adenocarcinoma of the lung. , 1984 .

[48]  R. Souhami,et al.  Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma. , 1983, Cancer treatment reports.

[49]  J. Palmer,et al.  Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma. , 1983, Cancer treatment reports.

[50]  P. Petruska,et al.  A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer , 1983, Cancer.

[51]  L. Einhorn,et al.  Vindesine: an effective agent in the treatment of non-small cell lung cancer. , 1982, Cancer treatment reports.

[52]  P. Petruska,et al.  Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases. , 1982, Cancer treatment reports.

[53]  I. Goldberg,et al.  Nervous system toxic effects of cancer therapy. , 1982, JAMA.

[54]  N. Vogelzang,et al.  Vindesine in bronchogenic carcinoma: a phase II trial. , 1982, American journal of clinical oncology.

[55]  C. Kosloff,et al.  Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. , 1982, Cancer treatment reports.

[56]  H. Hansen,et al.  Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung. , 1982, Cancer treatment reports.

[57]  N. Martini,et al.  Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. , 1981, Annals of internal medicine.

[58]  R. Gralla,et al.  Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung. , 1979, Cancer treatment reports.

[59]  I. Krakoff,et al.  Phase I trial of vindesine in patients with advanced cancer. , 1978, Cancer treatment reports.

[60]  J. O'fallon,et al.  Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer. , 1977, Cancer treatment reports.

[61]  R. Dyke,et al.  Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate). , 1977, Cancer treatment reviews.

[62]  H. Hansen,et al.  Combination chemotherapy of advanced lung cancer. A randomized trial , 1976, Cancer.

[63]  R. Arriagada,et al.  Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma. , 1992, Journal of the National Cancer Institute.

[64]  E. Quoix,et al.  [Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study]. , 1991, Bulletin du cancer.

[65]  R. Rosell,et al.  Quality of life during chemotherapy in non-small cell lung cancer patients. , 1989, Acta oncologica.

[66]  H. Hansen,et al.  Review of methodological problems in the interpretation of phase II trials in nonsmall-cell lung cancer. , 1988, Antibiotics and chemotherapy.

[67]  D. Ettinger,et al.  A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  A. Little,et al.  Protochemotherapy in non‐small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report , 1986, Cancer.

[69]  G. Sledge,et al.  Phase II trial of vindesine in adenocarcinoma of the lung. , 1984, Cancer treatment reports.

[70]  J. Hermann,et al.  Vindésine et chimiothérapie des cancers bronchiques non microcellulaires au stade. III: Essai randomisé en bithérapie-cyclophosphamide, vs cisplatinum. Présentation. Etude séquentielle de toxicité. Analyse intermédiaire , 1983 .

[71]  M. Bayssas,et al.  Vindesine: a new vinca alkaloid. , 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.